share_log

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Significant Decline in Short Interest

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Significant Decline in Short Interest

利盟基因控股公司(場外交易代碼:LXXGF)認為空頭股數的市場份額大幅下降
kopsource ·  2022/10/01 12:42

LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 99,700 shares, a decrease of 23.1% from the August 31st total of 129,600 shares. Based on an average daily trading volume, of 82,200 shares, the short-interest ratio is presently 1.2 days.

利盟基因控股有限公司(場外交易代碼:LXXGF-GET Rating)在9月份看到空頭股數的銷售額大幅下降。截至9月15日,空頭股數共有99,700股,比8月31日的129,600股減少了23.1%。以日均成交量八萬二千二百股計算,目前短息比率為一點二天。

LexaGene Stock Performance

Lexagene股票表現

OTCMKTS:LXXGF traded up 0.00 during midday trading on Friday, hitting 0.10. 7,000 shares of the company traded hands, compared to its average volume of 120,557. The firm's fifty day moving average is 0.11 and its 200-day moving average is 0.14. LexaGene has a 12-month low of 0.08 and a 12-month high of 0.48.

OTCMKTS:LXXGF在週五午盤交易中上漲0.00,觸及0.10。該公司有7000股易手,而其平均成交量為120,557股。該公司的50日移動均線切入位在0.11,200日移動均線切入位在0.14。Lexagene的12個月低點為0.08,12個月高位為0.48。

Get
到達
LexaGene
Lexagene
alerts:
警報:

About LexaGene

關於Lexagene

(Get Rating)

(獲取評級)

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Lexagene控股公司是一家生物技術公司,從事病原體檢測系統的研究、開發和商業化。它提供MiQLab,這是一種自動病原體檢測系統,旨在改變獸醫診斷、人類臨牀診斷、食品和水安全測試以及其他生命科學市場中的病原體檢測。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on LexaGene (LXXGF)
  • This Is A Memorable Time To Buy Into Micron Technology
  • Let Paychex Stock Work Hard For You
  • Thor Industries Hammers Out A Bottom
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • 免費獲取StockNews.com關於Lexagene的研究報告(LXXGF)
  • 這是買入美光科技的難忘時刻
  • 讓Paychex股票為您努力工作
  • 雷神工業走出谷底
  • 利潤下降對CarMax價值主張的挑戰
  • Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何?

Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.

接受Lexagene日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Lexagene和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論